Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001606302-26-000005

Chief Executive Officer sold 3,352 shares at $22.07 ($73,995)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McMinn Rachel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Sale : show line 1 in the form 10b5-1 −3,352 $22.07 $73,995 1,344,307 D
Open-market sales · 3,352 sh · avg $22.07 · $73,995
Loading xslF345X06/wk-form4_1774905414.xml…